Gates to invest $100M in dementia, Alzheimer's initiatives

IBM founder Bill Gates has a new target for his renowned philanthropic endeavors. The billionaire announced Nov. 13 that he will donate nearly $100 million to projects focused on researching dementia and Alzheimer's disease.

About $50 million of his nine-figure investment will go to the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments. The other half will go to a handful of start-up ventures working in Alzheimer’s research.

"You have a nearly 50 percent chance of developing the disease if you live into your mid-80s," Gates wrote about his recent initiative. "In the United States, it is the only cause of death in the top 10 without any meaningful treatments that becomes more prevalent each year. That trend will likely continue as baby boomers age, which means that more families will watch their loved ones suffer from cognitive decline and slowly disappear. Despite this growing burden, scientists have yet to figure out what exactly causes Alzheimer’s or how to stop the disease from destroying the brain."

These donations are personally from Gates and not a part of his well-known Bill & Melinda Gates Foundation.

Read Gates' extended thoughts on this recent move on his blog.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”